AIML Innovations Announces Departure of Tim Daniels from Board of Directors

Rhea-AI Summary

AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) announced the immediate departure of Tim Daniels from its Board of Directors. While stepping down from the Board, Daniels will continue supporting the company in an advisory capacity.

CEO Paul Duffy acknowledged Daniels' contributions to AIML's leadership and strategic direction during his tenure, expressing appreciation for his continued involvement as an advisor. The company stated it remains focused on strengthening its leadership and advisory network to support ongoing commercialization efforts and strategic growth initiatives.

AIML operates in the artificial intelligence and machine learning sectors, focusing on digital health and wellbeing solutions through its subsidiaries NeuralCloud Solutions, Quantum Sciences, AI Rx, and strategic partnership with Health Gauge (95.2% owned by AIML).

Positive

• Continuation of Tim Daniels' expertise in advisory capacity maintains valuable strategic input
• Company maintains focus on commercialization efforts and strategic growth initiatives

Negative

• Loss of key board member could impact corporate governance and strategic oversight

• Tim Daniels to Continue Supporting AIML in an Advisory Capacity

VANCOUVER, BC / ACCESS Newswire / April 25, 2025 / AI/ML INNOVATIONS INC. ("AIML" OR THE "COMPANY") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) announces that Tim Daniels has stepped down from his position on the Company's Board of Directors ("Board"), effective immediately.

Tim has been an integral part of AIML's leadership, contributing to the Company's strategic direction and governance during his tenure on the Board. His insights and dedication have played a key role in guiding AIML through important phases of growth and evolution.

Paul Duffy, CEO of AIML, commented:
"On behalf of the entire team at AIML, I would like to extend our sincere thanks to Tim for his contributions and leadership. We are pleased that Tim will continue to support the Company in an advisory capacity, where his experience and counsel will remain a valued asset as we advance our mission in AI-driven healthcare."

AIML remains focused on strengthening its leadership and advisory network to support ongoing commercialization efforts and strategic growth initiatives.

For more information about AIML:
For detailed information please see AIML's website or the Company's filed documents at www.sedarplus.ca.

Contact:
Blake Fallis
(778) 405-0882
info@aiml-innovations.com

About AI/ML Innovations Inc. https://aiml-innovations.com/
AIML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence: (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through its wholly owned subsidiaries, NeuralCloud Solutions Inc, Quantum Sciences Ltd, and AI Rx Inc., strategic partnerships with Health Gauge Inc. (95.2% owned by AIML), and other planned accretive investments, the Company continues to capitalize on expanding growth areas, to the benefit of all the Company's stakeholders. AIML's shares are traded on the Canadian Securities Exchange under the symbol "AIML", the OTCQB Venture Market under "AIMLF", and the Frankfurt Stock Exchange under "42FB".

On behalf of the Board of Directors:
Paul Duffy, Chairman

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements - Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements.

SOURCE: AI/ML Innovations, Inc.

View the original press release on ACCESS Newswire

FAQ

What impact will Tim Daniels' departure from AIML's Board have on the company's operations?

Tim Daniels will continue supporting AIML in an advisory role, maintaining his expertise within the company while stepping down from the Board of Directors. The company remains focused on its strategic growth initiatives.

What are AIML's (AIMLF) main business segments and subsidiaries?

AIML operates through subsidiaries NeuralCloud Solutions, Quantum Sciences, AI Rx, and owns 95.2% of Health Gauge, focusing on AI and machine learning solutions in digital health and wellbeing.

Where is AIMLF stock traded and what are its trading symbols?

AIML trades on the Canadian Securities Exchange (CSE:AIML), OTCQB Venture Market (OTCQB:AIMLF), and Frankfurt Stock Exchange (42FB).

What is AIML's current business strategy in the AI healthcare sector?

AIML focuses on AI-driven healthcare management solutions and precision support delivery, capitalizing on AI, machine learning, cloud computing, and digital platforms through its subsidiaries and strategic partnerships.